Colon cancer is world-wide a highly prevalent disease \[[@CR1]\] and approximately 15% of patients presents with a locally advanced tumour (T4 stage). Resection of T4 colon cancer can be challenging if it directly invades other organs or structures (T4b according to TNM7). This requires a multivisceral resection (MVR) that is conventionally performed using an open approach, but reports on laparoscopic MVRs are increasing.

Laparoscopic surgery for colon cancer was introduced in the late nineties. Several randomized trials showed the short-term benefits of laparoscopic colectomy as compared to open surgery \[[@CR2]--[@CR5]\]. A recent systematic review reported also long-term benefits, with lower risks of adhesion-related small bowel obstruction and incisional hernia \[[@CR6]\]. In the multicentre randomized COLOR trial \[[@CR7]\], the non-inferiority of laparoscopic surgery for colon cancer in terms of 3-year disease-free survival (3y DFS) was suggested. However, clinically suspected tumour invasion of adjacent structures (cT4b stage) was an exclusion criterion in the COLOR trial. With a reported conversion rate of up to 50% for the remaining T4 tumours, they proposed that an open approach could be more appropriate for T4 colon cancer.

Laparoscopic colectomy for colon cancer has become widely accepted and implemented in routine practice, but T4 stage still constitutes a relative contraindication for laparoscopic surgery. A laparoscopic approach might jeopardize radicality of the resection, with its impact on long-term oncological outcome \[[@CR8]\]. The aim of this study was to systematically review the currently available literature on laparoscopic surgery for T4 colon cancer, with regard to short- and long-term oncological outcomes, and to compare these with open surgery.

Methods {#Sec1}
=======

Literature search {#Sec2}
-----------------

A systematic search was performed on the 21st of February 2017. Studies describing laparoscopic surgery for T4 colon cancer were identified using MEDLINE, EMBASE, and PubMed using the search terms as provided in Supplementary Table 1. The review protocol was developed according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines \[[@CR9]\]. Two researchers independently screened titles and abstracts to select articles for full-text reading. In case of disagreement, discussion took place until consensus was reached. Relevant review articles and bibliographies of included studies were reviewed for additional relevant publications. No restrictions with respect to publication date were applied. Subsequently, two researchers performed full-text reading for the definitive selection of articles.

Study selection and quality assessment {#Sec3}
--------------------------------------

Articles were considered eligible if containing original data on laparoscopic resection of T4 colon cancer. T4 stage referred to either clinical or pathological stage. If studies included both colon and rectal cancer without separate data on outcome measures, authors were contacted to provide data for the relevant subgroup. If these were not available, studies were excluded. Furthermore, all authors were contacted to provide separate outcome data for the pT4a and pT4b subgroups.

Radicality of resection, postoperative morbidity and long-term oncological survival outcomes were considered the main study outcomes. Studies that did not report on at least one of the main outcome measures were excluded. Both comparative (laparoscopic versus open surgery) and non-comparative studies were eligible. Case reports and studies with less than 10 patients were excluded. The quality of the included articles was independently assessed by two authors using the nine-point Newcastle--Ottawa Scale \[[@CR10]\].

Data extraction {#Sec4}
---------------

General study characteristics (i.e. study design, in/exclusion criteria), baseline patient and tumour characteristics, operative characteristics (setting, need for conversion, MVR), and data on multimodality treatment (i.e. systemic therapy) were extracted from the included studies. Outcome measures included postoperative complications (\<30 days, not further predefined), postoperative mortality, radicality of resection, disease-free survival (DFS), and overall survival (OS). In case of comparative studies, relevant data were also extracted for the subgroup that received open surgery for T4 colon cancer. If available, data on oncological outcomes were retrieved for T4a and T4b stages separately. Data extraction was performed by two researchers independently.

Statistical analyses {#Sec5}
--------------------

Pooled averages were calculated for perioperative outcome measures. Pooled proportions with 95% confidence intervals (95%CI) were calculated using an inverse variance method (random effects model) in RStudio version 3.2.3 (R Foundation for Statistical Computing, Vienna, Austria 2016). For the purpose of comparing laparoscopic with open surgery, risk ratios were calculated with corresponding 95% confidence intervals (CI) using an inverse variance method (random effects model). The *I* ^2^ statistic was calculated in order to evaluate heterogeneity of the included studies. Meta-analyses were performed using Review Manager 5.3 (The Nordic Cochrane Centre, The Cochrane Collaboration, Copenhagen, Denmark 2014). A *p* value of less than 0.05 was considered statistically significant.

Results {#Sec6}
=======

Included studies {#Sec7}
----------------

A total of 2689 hits were identified by searching MEDLINE, EMBASE, and Pubmed. The further selection process is displayed in Supplementary Fig. 1 and led to 56 articles eligible for full-text reading. Finally, 13 studies (23%) were included, all published between 2012 and 2017 (Table [1](#Tab1){ref-type="table"}) \[[@CR11]--[@CR23]\]. There were no randomized controlled trials. Twelve studies were comparative observational cohort studies, including three studies applying matching or weighting. De'Angelis \[[@CR11]\] used propensity score matching including the following variables in the regression model: age, sex, ASA score, surgical procedure, tumour location, tumoural and nodal stage, tumour size, MVR, and year of surgery. Elnahas \[[@CR13]\] used inverse probability of treatment weighting (IPTW) creating a propensity score that represents the probability a patient was approached with laparoscopic resection, including age, sex, BMI, high ASA (\>2), renal failure, chronic obstructive pulmonary disease (COPD), congestive heart failure (CHF), bleeding disorder, preoperative chemotherapy, metastasis, nodal disease, rectosigmoid resection, and emergency cases. Vignali \[[@CR22]\] performed a case-matched control study and matched for disease stage (II/III/IV), ASA score, year of surgery (±3 years), and sex.Table 1Characteristics of the included studiesReferencesDesignPopulationExclusion criteriaSample sizeDe'Angelis et al. \[[@CR11]\]Retrospective, two centers, comparative, PSM, ITTpT4 colon cancer (TNM7)Emergency procedures\
M1Lap: 106\
Conv: 13 (12%)\
Open: 106Chan et al. \[[@CR12]\]Retrospective, single center, comparative, ITTpT4 colon cancer (TNM6/7)Emergency proceduresM1\
Direct invasion to adjacent organsLap: 93\
Conv: 8 (8.6%)\
Open: 59Elnahas et al. \[[@CR13]\]Retrospective, multicenter, comparative, IPTW, ITTpT4a colon cancer\
(TNM7)T4b;\
Tumor below peritoneal reflectionLap: 455\
Conv: 8 (11%)\
Open: 406Kang et al. \[[@CR14]\]Retrospective, single center, comparative, ITTpT4 colon cancer (TNM7)M1\
Robotic surgeryLap: 52\
Conv: 4 (7.7%)\
Open: 57Kim et al. \[[@CR15]\]Retrospective, single center, comparative, ITTpT4 colon cancer (TNM7)Non-resectional surgery;\
Bypass surgery;\
FAP;\
HNPCC\
M1Lap: 51\
Conv: 7 (14%)\
Open: 66Nagasue et al. \[[@CR16]\]Prospective, single center, comparative, ITTPatients receiving MVR for colorectal cancer (TNM7),\
*Separate data on colon only included in this analysis*Emergency surgery;\
Synchronous resection of liver metastases;\
Pelvic exenteration;\
Pancreaticoduodenectomy;\
Distal pancreatectomy:\
Resection of spleen, ureter, gallbladder, neurovascular bundle, psoas muscle, or sacrum.\
Palliative resections;Lap: 39\
Conv: 3 (7.7%)\
pT4: 30 (77%)\
Open: 53\
pT4: 41 (77%)Park et al. \[[@CR17]\]Retrospective, single center, comparative, ITTcT4 colon cancer (TNM7)Recurrent cancer\
M1\
FAP, HNPCC\
Neoadjuvant therapyLap: 71\
Conv: 4 (5.6%)\
Open: 222Sammour et al. \[[@CR18]\]Retrospective, multicenter, comparative, ITTColon cancer\
*Separate data on pT4 only included in this analysis*--Lap: 89\
Conv: 13 (15%)\
Open: 184Shukla et al. \[[@CR19]\]Retrospective, single center, comparative, ITTpT4 colon cancer\
(TNM7)M1Lap: 61\
Conv: 13 (21%)\
Open: 22Takahashi et al. \[[@CR20]\]Retrospective, single center, ITTPatients receiving MVR for colon cancer (TNM7)Recurrent cancer\
Rectal cancerLap: 48\
Conv: 6 (13%)\
Open: 36Vallribera Valls et al. \[[@CR21]\]Retrospective, single center, comparative, cohort\
ITTColon cancer (TNM6)\
*Separate data on pT4 only included in this analysis.*Emergency procedures\
M1\
MVR\
ASA 4\
Previous colonic surgeryLap: 69\
Conv: 4 (5.9%)\
Open: 76Vignali et al. \[[@CR22]\]Prospective, single center, comparative,\
case matched, ITTpT4 colon cancer (TNM7)Emergency proceduresLap: 70\
Conv: 5 (7.1%)\
Open 70Allaix et al. \[[@CR23]\]Retrospective, single center,\
non-comparativeColorectal cancer (TNM7)\
*Separate data on pT4 colon cancer only included in this analysis*cM1\
Preoperatively evident adjacent organ invasion\
Obstruction/perforation\
History of colorectal surgeryLap: 13\
Conv: 3 (23%)*Conv* conversion; *IPTW* inverse probability of treatment weighting; *ITT* intention to treat analysis; *MVR* multivisceral resection; *PSM* propensity score matching

Three multicentre studies were included and ten single-centre studies. All studies together comprised 1217 patients that received laparoscopic surgery and 1357 that underwent open surgery. In all studies, converted patients were included in the laparoscopic group as intention to treat principle. After contacting the authors of combined colon and rectal cancer series, four studies provided separate data of T4 colon cancer \[[@CR18], [@CR21], [@CR23], [@CR24]\]. Regarding pathological versus clinical staging, ten studies included only patients with pT4 stage and inclusion was based on cT4 stage in three studies, with confirmation of pT4 by the pathologist in 77, 38, and 50%. Regarding pathological subgroups of pT4, one study included only pT4a stage \[[@CR13]\], and in nine other studies, mainly (\>60%) pT4a patients were included \[[@CR11], [@CR14], [@CR17]--[@CR19], [@CR21]--[@CR23], [@CR25]\]. In two studies, MVR was the main focus, resulting in mostly pT4b stage \[[@CR16], [@CR20]\]. In eight studies, patients with metastatic disease were excluded. Emergency procedures were included in five studies \[[@CR13]--[@CR15], [@CR18], [@CR19]\], excluded in six other studies \[[@CR11], [@CR12], [@CR16], [@CR21]--[@CR23]\], and not mentioned in the two remaining studies \[[@CR17], [@CR20]\].

Using the Newcastle--Ottawa Scale, two studies scored 9 out of 9 points, one study 8, three studies 7, five studies 6, and two studies were awarded 5 points (Supplementary Table 2).

Patient, disease, and treatment characteristics {#Sec8}
-----------------------------------------------

Patient and disease characteristics are displayed in Table [2](#Tab2){ref-type="table"} for the laparoscopic and open subgroups separately. In Supplementary Table 3, data on operative characteristics are displayed. Conversion rates varied from 5.6 to 23%, with a pooled proportion of 0.11 (95% CI:0.09--0.14). In six of the eight comparative studies that also included MVR \[[@CR11], [@CR14], [@CR15], [@CR17], [@CR19], [@CR22]\], the proportion of MVR was higher in the open subgroups and the remaining two comparative studies included 100% MVR \[[@CR20], [@CR24]\].Table 2Patient, disease, and treatment characteristicsReferencesGroupAge (years)ASAT4a/T4b*N*+-stageM1-stageNeoadjuvant therapyAdjuvant chemotherapyDe'Angelis et al. \[[@CR11]\]Lap (*n* = 106)\
Open (*n* = 106)Median: 71 (18--94)\
Median: 76 (27--91)\
*p* = 0.208≥3: 24 (23%)\
≥3: 30 (28%)\
*p* = 0.516pT4a: 91 (86%)\
pT4b: 15 (14%)\
pT4a: 86 (81%)\
pT4b: 20 (19%)\
*p* = 0.46061 (58%)\
66 (62%)\
*p* = 0.5730\
0NR63 (59%)\
53 (50%)\
*p* = 0.214Chan et al. \[[@CR12]\]Lap (*n* = 93)\
Open (*n* = 59)NSNSNR54 (58%)\
46 (78%)\
*p* = 0.012NSNRNRElnahas et al. \[[@CR13]\]Lap (*n* = 455)\
Open (*n* = 406)67 (SD 14)\
67 (SD 15)\
*p* = 0.92≥3: 27 (6.3%)\
≥3: 28 (7.1%)\
*p* = 0.64T4a only296 (69%)\
268 (69%)\
*p* = 0.99122 (28%)\
111 (28%)\
*p* = 0.9820 (4.6%)\
19 (4.7%)\
*p* = 0.94NRKang et al. \[[@CR14]\]Lap (*n* = 52)\
Open (*n* = 57)62 (SD 14)\
65 (SD 12)≥3: 8 (15%)\
≥3: 3 (5.3%)pT4a: 45 (87%)pT4b: 7 (14%)\
pT4a: 39 (69%)pT4b: 18 (32%)\
*p* = 0.02535 (67%)\
33 (58%)\
*p* = 0.5770\
0NR42 (81%)\
43 (75%)\
*p* = 0.502Kim et al. \[[@CR15]\]Lap\
(*n* = 51)\
Open\
(*n* = 66)70 (SD 12)\
67 (SD 11)\
*p* = 0.181≥3: 4 (7.8%)\
≥3: 11 (17%)\
*p* = 0.110pT4a: 49 (96%)\
pT4b: 2 (3.9%)\
pT4a: 54 (82%)\
pT4b: 12 (18%)\
*p* = 0.01834 (67%)\
40 (61%)\
*p* = 0.4680\
0NRNR\
NRNagasue et al. \[[@CR16]\]Lap\
(*n* = 39)\
Open (*n* = 53)65 (SD 13)\
64 (SD 13)\
*p* = 0.843NRpT1-3: 9 (23%)\
pT4a: 7 (18%)\
pT4b: 23 (59%)\
pT1-3: 12 (23%)\
pT4a: 4 (7.5%)\
pT4b: 37 (70%)\
*p* = 0.27527 (69%)\
21 (39%)\
*p* = 0.00515 (39%)\
10 (19%)\
*p* = 0.0370 (0%)\
2 (3.8%)\
*p* = 0.50615 (63%) (M0 only (*n* = 24))\
16 (37%) (M0 only (*n* = 43))\
*p* = 0.047Park et al. \[[@CR17]\]Lap (*n* = 71)\
Open (*n* = 222)Median: 59 (36--80)\
Median: 61 (17--84)\
*p* = 0.321≥2: 38 (54%)\
≥2: 132 (60%)\
*p* = 0.377cT4a: 58 (82%)\
cT4b: 13 (18%)\
cT4a: 130 (59%)\
cT4b: 92 (41%)\
*p* \< 0.00143 (61%)\
104 (47%)\
*p* = 0.0850\
00\
060 (85%)\
171 (77%)\
*p* = 0.179Sammour et al. \[[@CR18]\]Lap (*n* = 89)\
Open (*n* = 184)67 (SD 14)\
67 (SD 14)\
*p* = 0.54026 (48%)\*\
53 (44%)\
*p* = 0.626pT4a: 48 (81%)\*pT4b: 11(19%)\
pT4a: 80 (67%)pT4b: 40 (33%)\
*p* = 0.04166 (74%)\*\
135 (74%)\
*p* = 0.99726 (29%)\*\
65 (36%)\
*p* = 0.3010 (0%)\
3 (1.6%)\
*p* = 0.55340 (64%) (M0 only (*n* = 63))\
65 (55%) (M0 only (*n* = 118))\
*p* = 0.275Shukla et al. \[[@CR19]\]Lap (*n* = 61)\
Open\
(*n* = 22)Median: 70 (31--88)\
Median: 71 (35--93)\
*p* = 0.680≥3: 27 (44%)\
≥3:10 (46%)\
0.923pT4a: 53 (87%)\
pT4b: 8 (13%)\
pT4a: 15 (68%)\
pT4b: 7 (32%)\
*p* = 0.10237 (61%)\
11 (50%)\
*p* = 0.6670\
01 (1.6%)\
2 (9.0%)\
*p* = 0.17053 (87%)\
16 (73%)\
*p* = 0.182Takahashi et al. \[[@CR20]\]Lap (*n* = 48)\
Open (*n* = 36)Median: 69 (49--86)\
Median: 62 (46--88)\
*p* = 0.135PS≥1: 11 (23%)\
PS≥1: 16 (44%)\
*p* = 0.037pT4b: 22 (46%)\
pT4b: 20 (56%)\
*p* = 0.37814 (29%)\
7 (19%)\
*p* = 0.39713 (27%)\
8 (22%)\
*p* = 0.397(6.3%)\
(25%)\
*p* = 0.01510 (71% of stage III)\
4 (57% of stage III)Vallribera Valls et al. \[[@CR21]\]Lap\
(*n* = 69)\
Open (*n* = 76)71 (SD 12)\
70 (SD 12)\
*p* = 0.612≥3: 24 (35%)\
≥3: 20 (26%)\
*p* = 0.26841 (59%)\
43 (58%)\
*p* = 0.8730\
0NRNRVignali et al. \[[@CR22]\]Lap\
Open65 (SD 13)\
64 (SD 21)\
*p* = 0.21Mean: 1.94 (SD 0.4)\
Mean: 1.94 (SD 0.6)\
*p* = 0.88pT4a: 52 (74%)\
pT4b: 18 (26%)\
pT4a: 46 (66%)\
pT4b: 24 (34%)\
*p* = 0.4932 (46%)\
32 (46%)\
*p* = 0.555 (7.1%)\
5 (7.1%)\
*p* = 0.550 (0%)\
0 (0%)52 (74%)\
56 (80%)\
*p* = 0.66Allaix et al. \[[@CR23]\]Lap (*n* = 13)Mean: 60 (7.8)NRNR. Mainly T4a, since organ invasion on preoperative imaging was an exclusion criteria10 (77%)0NR12 (92%)Age is displayed in median (range) or mean (SD)*Lap* laparoscopic surgery; *NR* not reported; *Open* open surgery;*PS* performance status\* Excluding missing cases

Postoperative complication rates were described in 11 of the 13 studies, without clear definitions. Postoperative (30-day, early) complication rates ranged from 7.7 to 30% in laparoscopic groups and from 21 to 49% in the open cohorts, mainly including anastomotic leakage, (intra-abdominal) abscess, ileus, urinary tract infection, and wound infection. Pooled proportion of postoperative complications was 0.23 (95% CI: 0.19--0.27) for laparoscopy, and 0.35 (95% CI: 0.31--0.40) for open surgery (Table [4](#Tab4){ref-type="table"}). Pooled postoperative mortality rates were 0.02 (95% CI: 0.01--0.04) and 0.03 (95% CI: 0.02--0.06), respectively. Meta-analysis of comparative studies reporting on postoperative complications revealed a risk ratio for laparoscopic versus open surgery of 0.65 for postoperative complications \[95% CI: 0.55--0.77; *p* \< 0.001, (heterogeneity: *I* ^2^ 0%, *p* = 0.51)\].

Adjuvant chemotherapy was applied in 55--100% of patients after laparoscopic surgery and in 37--80% after open resection. Time to adjuvant chemotherapy was only reported in one study \[[@CR15]\]; 34 days (SD9) in the laparoscopic group versus 36 (SD21) days after open resection (*p* = 0.510).

Oncological outcomes {#Sec9}
--------------------

Eleven studies reported on radicality of resection (R0). Proportions of radical resections varied from 74 to 100% for laparoscopic surgery and from 76 to 100% in the open group (Table [3](#Tab3){ref-type="table"}). Pooled proportions were 0.96 (95% CI: 0.91--0.99) and 0.96 (95% CI: 0.90--0.98), respectively (Table [4](#Tab4){ref-type="table"}). Meta-analysis revealed no significant difference in radicality of resection between laparoscopic and open surgery (RR: 1.00 (95% CI: 0.98--1.01), *p* = 0.80) (Supplementary Fig. 2).Table 3Oncological outcomesReferencesGroupR0 resection rateOverall survivalDisease-free survivalDe'Angelis et al. \[[@CR11]\]Lap (*n* = 106)\
Open (*n* = 106)100 (94%)\
99 (93%)\
*p* = 13y OS: 77%\
5y OS: 59%\
3y OS: 70%\
5y OS: 60%\
*p* = 0.8643y DFS: 66%\
5y DFS: 58%\
3y DFS: 55%\
5y DFS: 50%\
*p* = 0.261Chan et al. \[[@CR12]\]Lap (*n* = 93)\
Open (*n* = 59)92 (99%)\
59 (100%)3y OS: 70%\
3y OS: 54%\
*p* = 0.3353y DFS: 59%\
3y DFS: 46%\
*p* = 0.113Elnahas et al. \[[@CR13]\]Lap (*n* = 455)\
Open (*n* = 406)341 (74%)\
313 (76%)\
*p* = 0.24NRNRKang et al. \[[@CR14]\]Lap (*n* = 52)\
Open (*n* = 57)51 (98%)\
55 (96%)\
NS5y OS: 61%\
5y OS: 62%\
*p* = 0.8175y DFS: 54%\
5y DFS: 63%\
*p* = 0.980Kim et al. \[[@CR15]\]Lap (*n* = 51)\
Open (*n* = 66)49 (96%)\
63 (96%)\
*p* = 0.8693y OS: 83%\
3y OS: 76%\
NS3y DFS: 62%\
3y DFS: 64%\
NSNagasue et al. \[[@CR16]\]Lap (*n* = 39)\
Open (*n* = 53)38 (97%)\
53 (100%)\
*p* = 0.241NRNRPark et al. \[[@CR17]\]Lap (*n* = 71)\
Open (*n* = 222)NR5y OS: 95%\
5y OS: 87%\
*p* = 0.2205y DFS: 82%\
5y DFS: 74%\
*p* = 0.433Sammour et al. \[[@CR18]\]Lap (*n* = 89)\
Open (*n* = 184)NR3y OS: 72% 5y OS: 54%\
3y OS: 74% 5y OS: 58%\
*p* = 0.338 *stage II/III only*3y DFS: 59% 5y DFS: 49%\
3y DFS: 65% 5y DFS: 54%\
*p* = 0.663 *stage II/III only*Shukla et al. \[[@CR19]\]Lap (*n* = 61)\
Open (*n* = 22)61 (100%)\
21 (96%)\
*p* = 0.2653y OS: 82%\
3y OS: 81%\
*p* = 0.5253y DFS: 76%\
3y DFS: 64%\
*p* = 0.848Takahashi et al. \[[@CR20]\]Lap (*n* = 48)\
Open (*n* = 36)46 (96%)\
35 (97%)\
*p* = 0.7343y OS: 94%\
3y OS: 80%\
*p* = 0.441 *stage II/III only*NR\
NR\
*p* = 0.846 *stage II/III only*Vallribera Valls et al. \[[@CR21]\]Lap (*n* = 69)\
Open (*n* = 76)69 (100%)\
76 (100%)3y OS: 72%\
5y OS: 62%\
3y OS: 75%\
5y OS: 62%\
*p* = 0.7153y DFS: 60%\
5y DFS: 54%\
3y DFS: 56%\
5y DFS: 49%\
*p* = 0.688Vignali et al. \[[@CR22]\]Lap (*n* = 70)\
t4b (*n* = 18)\
t4a (*n* = 52)\
Open (*n* = 70)\
t4b (*n* = 24)\
t4a (*n* = 46)67 (96%)\
15 (83%)\
52 (100%)\
67 (96%)\
21 (88%)\
46 (100%)\
*p* = 0.51\
*p* = 0.715y OS: 53%\
5y OS: 42%\
5y OS: 59%\
5y OS: 59%\
5y OS: 48%\
5y OS: 64%\
*p* = 0.18\
*p* = 0.42\
*p* = 0.715y DFS: 47%\
5y DFS: 51%\
*p* = 0.20Allaix \[[@CR23]\]Lap (*n* = 13)13 (100%)3y OS: 69%\
5y OS: 54%3y DFS: 39%\
5y DFS: 39%*DFS* disease-free survival; Lap: laparoscopic surgery; *NR* not reported; *Open* open surgery; *OS* overall survival; *3y* 3-year; *5y* 5-year\* Only study that included M1 patients in survival analyses Table 4Pooled proportions for laparoscopic and open surgeryLaparoscopic surgeryNo. of studiesSample sizeEventsPooled proportions (95%CI)*I* ^2^ (%)*p*-valueConversion1312171310.11 (0.09--0.14)370.175*Postoperative outcomes*Complications116691430.23 (0.19--0.27)240.212Postoperative mortality845860.02 (0.01--0.04)00.841*Oncological outcomes*R0 resection rate1110579270.96 (0.91--0.99)86\<0.0013y DFS74823020.62 (0.57--0.68)320.1865y DFS64002330.58 (0.47--0.68)750.0133y OS85304070.77 (0.71--0.82)450.0805y OS64002620.67 (0.55--0.77)79\<0.001Open surgeryNo. of studiesSample sizeEventsPooled proportions (95%CI)*I* ^2^ (%)*p*-value*Postoperative outcomes*Complications108923180.35 (0.31--0.40)520.029Postoperative mortality742090.03 (0.02--0.06)00.685*Oncological outcomes*R0 resection rate109518410.96 (0.90--0.98)84\<0.0013y DFS65133040.58 (0.52--0.64)440.1155y DFS56453890.58 (0.47--0.69)86\<0.0013y OS75493960.72 (0.66--0.78)520.0525y OS56454450.67 (0.53--0.79)91\<0.001*DFS* disease-free survival; *OS* overall survival; *3y* 3-year; *5y* 5-year\* The study of Vignali et al left out of pooled survival proportions, due to inclusion of M1 stage

Endpoints used for long-term outcomes varied amongst the studies (Table [3](#Tab3){ref-type="table"}). The pooled proportions are displayed in Table [4](#Tab4){ref-type="table"}. Using meta-analysis, no statistically significant differences were found between laparoscopic and open surgery for any survival measure: RR 1.07 (95% CI: 0.96--1.20) for 3-year DFS, RR 1.04 (95% CI: 0.95--1.15) for 5-year DFS, RR 1.07 (95% CI: 0.99--1.14) for 3-year OS, and RR 1.05 (95% CI: 0.98--1.12) for 5-year OS (Supplementary Table 4).

For subgroup analyses of T4a stage, seven studies were selected of which six provided separate data for pT4a \[[@CR11], [@CR13], [@CR16], [@CR18], [@CR21], [@CR22]\] and in one additional study, pT4a was included in \>80% in both the open and laparoscopic groups \[[@CR15]\]. Pooled proportions of R0 resection of these studies were 0.94 (95% CI: 0.81--0.98) and 0.94 (95% CI: 0.82--0.98) after laparoscopic and open surgery, respectively (RR 1.00, 95% CI: 0.97--1.02, *p* = 0.75 (*I* ^2^ = 0%, *p* = 0.99), 6 studies). Furthermore, no significant difference was found for any survival measure: RR 1.09 (95% CI: 0.93--1.29, 3 studies) for 3-year DFS, RR 1.03 (95% CI: 0.82--1.31, 2 studies) for 5-year DFS, RR 1.11 (95% CI: 1.00--1.25, 3 studies) for 3-year OS, and RR 0.98 (95% CI: 0.83--1.173, 3 studies) for 5-year OS.

Considering T4b stage, five studies provided separate data (Table [3](#Tab3){ref-type="table"}). Pooled proportions of R0 resection of these studies were 0.91 (95% CI: 0.80--0.96) and 0.93 (95% CI: 0.80--0.98) after laparoscopic and open surgery, respectively (RR 0.99, 95% CI: 0.92--1.05, *p* = 0.68 (*I* ^2^ = 0%, *p* = 0.69), 4 studies). Although in favour of open surgery, no significant differences were found for any survival measure: RR 0.91 (95% CI: 0.62--1.34, 1 study) for 3-year DFS, RR 0.91 (95% CI: 0.0.58--1.42, 1 study) for 5-year DFS, RR 0.85 (95% CI: 0.63--1.15, 1 study) for 3-year OS, and RR 0.96 (95% CI: 0.69--1.35, 2 studies) for 5-year OS.

Discussion {#Sec10}
==========

This systematic review of the literature revealed that only observational cohort studies on laparoscopic surgery for T4 colon cancer have been published. The open groups more often included MVRs, and six studies including both pT4a and pT4b stages provided separate outcome data. The pooled proportion of radical resection was 96% for both laparoscopic and open surgery. Analysing evaluable studies for different pT4 stages revealed pooled R0 resection rates for pT4a of 94% in both the laparoscopic and open groups. For pT4b, pooled R0 resection rates were 0.91 and 0.93. Available long-term oncological outcome measures in comparative studies did not show any significant differences between laparoscopic and open surgery for locally advanced colon cancer in both overall, T4a and T4b subgroup analyses.

Given the non-randomized design of the comparative studies, it should be noted that the approach of surgery (laparoscopic or open) has been chosen by the surgeon for specific reasons and with several influencing factors. Criteria on which this decision was made are often hard to determine retrospectively. In general, a laparoscopic approach for T4 colon cancer is used in patients with less extensive tumours requiring less complex procedures. This is confirmed by the comparative studies including MVR, showing a lower proportion of MVR in the laparoscopic groups compared to the open groups. The surgeon's experience in minimally invasive surgery is crucial, and the laparoscopic and open resections from one institute might have been performed by different surgeons. Furthermore, when there is only peritoneal penetration (T4a), T4 stage is often diagnosed postoperatively, having less influence on the choice of the surgical approach. Achieving an R0 resection of T4a tumours is comparable to T3 tumours, because serosal ingrowth does not threaten margins. T4b tumours invade adjacent structures and require more complex (multivisceral) surgery \[[@CR26], [@CR27]\]. Inequality in distribution of T4a and T4b stages between the laparoscopic and open groups may significantly influence the results of comparative studies. In six of the included comparative studies, the proportion of T4b was substantially higher in the open group \[[@CR14], [@CR15], [@CR17]--[@CR20]\]. To overcome these methodological problems, Elnahas et al. excluded T4b stage \[[@CR13]\] and Nagasue selected only MVR \[[@CR24]\]. Furthermore, three studies applied matching or weighing in order to correct for baseline differences between the two surgical approaches. Only De'Angelis et al. \[[@CR11]\] matched for T4a/b stage.

Considering the fact that laparoscopic surgery was likely being performed in more 'favourable' T4 colon cancers, one might argue that the pooled 96% radicality of resection should actually be considered worse compared to the similar radicality after open resection of more high-risk T4 cancers. Also the comparable survival probabilities should be interpreted with this allocation bias kept in mind. Selecting (mainly) T4a tumours allows for a more reliable comparison between the surgical approaches. The similar R0 resection rates for laparoscopic and open surgery in this subgroup analysis suggest that laparoscopic surgery for T4a stage is safe. The oncological safety of a minimally invasive multivisceral resection is, however, not clear based on the present data. The pooled radical resection rate after laparoscopic surgery for exclusively T4b stage was only 91%. Allocation bias may particularly play a crucial role in these tumours that invade surrounding organs by probably selecting, for example, a (limited) abdominal wall resection for a laparoscopic approach, whereas extensive multiorgan resections are often performed using open surgery. Future prospective studies differentiating between limited and extensive T4b tumours should point out the suitability of laparoscopic surgery for (part of) the T4b subgroup.

The risk of developing a postoperative complication was significantly lower after laparoscopic surgery as compared to open surgery (RR 0.65; 95% CI: 0.55--0.77, *p* \< 0.001). However, in five out of ten comparative studies reporting on postoperative complications, substantially more MVRs were performed in the open group as compared to the laparoscopic group (Supplementary Table 3) \[[@CR14], [@CR15], [@CR17], [@CR19], [@CR22]\]. A MVR is accompanied by more postoperative complications than just a segmental colectomy \[[@CR26], [@CR27]\]. The benefit of a laparoscopic approach for MVR might be limited, especially considering the fact that often large extraction incisions have to be made to remove the relatively large MVR specimens. Furthermore, in the open subgroups of three studies \[[@CR15], [@CR18], [@CR19]\], significantly higher proportions of emergency procedures were included, with its impact on postoperative complications \[[@CR28]\].

The influence of expertise on oncological outcomes is suggested based on a wide range in reported R0 resection rates of 74--100%. The study of Elnahas et al. \[[@CR13]\] was a multi-institutional cohort study and used data from a (bi)nationwide database, showing overall R0 resection rates of 75%. Information on surgical experience and hospital volume was not provided, but the nationwide character of the study suggests a substantial contribution of non-expert centres. Potentially, centralization of care contributes to better R0 resection rates.

This systematic review has several limitations. An important limitation is the relatively low quality of evidence of the included studies as already discussed. Only three multicentre studies were included, suggesting publication bias of single-centre studies originating from expert centres. Furthermore, substantial heterogeneity between the studies exists because of the different patient populations assessed with regard to definition of T4 (clinical T4 versus pathological T4, T4a versus T4b). Duration of follow-up was relatively short, with two studies reporting on 3-year oncological outcomes \[[@CR15], [@CR29]\], while median follow-up was only 27 and 32 months, respectively. Also, with conversion rates of up to 23%, the intention to treat analysis might muddle the reported outcomes.

In conclusion, current literature does not provide the definitive answer on oncological safety of minimally invasive surgery for locally advanced colon cancer. Based on subgroup analysis, we cautiously conclude that laparoscopic surgery for T4a tumours might be safe, whereas it seems less appropriate for T4b tumours requiring multivisceral resection. Laparoscopic resection of T4 colon cancer should probably only be performed in selected patients by experienced surgeons. These selection criteria and level of experience have to be defined more precisely in future studies.
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